Comment
Biologic therapy for inflammatory bowel disease comes of age
- PMID: 18377800
Item in Clipboard
Comment
Biologic therapy for inflammatory bowel disease comes of age
Curr Gastroenterol Rep.
2007 Dec.
No abstract available
Comment on
-
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.Ann Intern Med. 2007 Jun 19;146(12):829-38. doi: 10.7326/0003-4819-146-12-200706190-00159. Epub 2007 Apr 30. Ann Intern Med. 2007. PMID: 17470824 Clinical Trial.
Similar articles
-
Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease.Am J Obstet Gynecol MFM. 2022 Jan;4(1):100518. doi: 10.1016/j.ajogmf.2021.100518. Epub 2021 Oct 22. Am J Obstet Gynecol MFM. 2022. PMID: 34688951
-
Biologic therapy for inflammatory bowel disease comes of age.Curr Gastroenterol Rep. 2008 Dec;10(6):565-6. Curr Gastroenterol Rep. 2008. PMID: 19006611 No abstract available.
-
Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.Aliment Pharmacol Ther. 2020 Mar;51(5):527-533. doi: 10.1111/apt.15637. Epub 2020 Jan 28. Aliment Pharmacol Ther. 2020. PMID: 31990422 Free PMC article.
-
Biologic therapy of inflammatory bowel disease.Gastroenterology. 2002 May;122(6):1592-608. doi: 10.1053/gast.2002.33426. Gastroenterology. 2002. PMID: 12016425 Review.
-
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.Inflamm Bowel Dis. 2020 May 12;26(6):949-959. doi: 10.1093/ibd/izz244. Inflamm Bowel Dis. 2020. PMID: 31665288